Merck (MRK) and Ridgeback Biotherapeutics Provide Update on New Studies of LAGEVRIO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Merck (MRK) and Ridgeback Biotherapeutics Provide Update on New Studies of LAGEVRIO

Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO™ (molnupiravir)

October 6, 2022 7:50 PM EDT

A preliminary analysis of the University of Oxfords open label, prospective real-world evidence study, PANORAMIC, conducted in the UK in highly-vaccinated adults mostly... More